Leerink Partnrs Brokers Increase Earnings Estimates for RAPT
RAPT Therapeutics, Inc. (NASDAQ:RAPT – Free Report) – Research analysts at Leerink Partnrs raised their FY2024 earnings estimates for shares of RAPT Therapeutics in a research note issued on Wednesday, February 5th. Leerink Partnrs analyst T. Smith now forecasts that the company will post earnings per share of ($1.51) for the year, up from their […]
![Leerink Partnrs Brokers Increase Earnings Estimates for RAPT](https://www.americanbankingnews.com/wp-content/timthumb/timthumb.php?src=https://www.marketbeat.com/logos/rapt-therapeutics-inc-logo-1200x675.png?v=20221209140441&w=240&h=240&zc=2)